Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B BEER

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Journal of Medical Primatology|January 8, 1999
SIVmac vaccine studies using whole inactivated virus antigen sequentially depleted of viral proteinsS Norley, B Beer, H König, et al.
European Cells & Materials|October 17, 2003
Fabrication of highly porous scaffold materials based on functionalized oligolactides and preliminary results on their use in bone tissue engineeringS Vogt, Y Larcher, B Beer, et al.
Science (New York, N.Y.)|July 30, 1982
The cholinergic hypothesis of geriatric memory dysfunctionR T Bartus, R L Dean, B Beer, et al.
Immunology Letters|April 15, 1999
Why are the natural hosts of SIV resistant to AIDS?S Norley, B Beer, S Holzammer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivoB Beer, M Baier, J zur Megede, et al.
Pharmacology, Biochemistry, and Behavior|December 1, 1978
Enhancement of 3H-diazepam binding by SQ 65,396: a novel anti-anxiety agentB Beer, C A Klepner, A S Lippa, et al.
Virology|May 1, 1996
Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virusS Norley, B Beer, D Binninger-Schinzel, et al.
Journal of Immunological Methods|October 31, 2001
Analysis of SIV-specific CTL in the rhesus macaque model of AIDS: the use of simian fibroblasts as an alternative source of target cells for chromium release assaysS Sharpe, B Beer, G Hall, et al.
Veterinary Microbiology|October 9, 1999
Treatment of feline leukemia virus (FeLV) infectionK Hartmann, A Block, G Ferk, et al.
European Journal of Pharmacology|June 7, 1985
Interaction of amoxapine with muscarinic cholinergic receptors: an in vitro assessmentJ Coupet, S K Fisher, C E Rauh, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Journal of Medical Primatology|January 8, 1999
SIVmac vaccine studies using whole inactivated virus antigen sequentially depleted of viral proteinsS Norley, B Beer, H König, et al.
European Cells & Materials|October 17, 2003
Fabrication of highly porous scaffold materials based on functionalized oligolactides and preliminary results on their use in bone tissue engineeringS Vogt, Y Larcher, B Beer, et al.
Science (New York, N.Y.)|July 30, 1982
The cholinergic hypothesis of geriatric memory dysfunctionR T Bartus, R L Dean, B Beer, et al.
Immunology Letters|April 15, 1999
Why are the natural hosts of SIV resistant to AIDS?S Norley, B Beer, S Holzammer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivoB Beer, M Baier, J zur Megede, et al.
Pharmacology, Biochemistry, and Behavior|December 1, 1978
Enhancement of 3H-diazepam binding by SQ 65,396: a novel anti-anxiety agentB Beer, C A Klepner, A S Lippa, et al.
Virology|May 1, 1996
Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virusS Norley, B Beer, D Binninger-Schinzel, et al.
Journal of Immunological Methods|October 31, 2001
Analysis of SIV-specific CTL in the rhesus macaque model of AIDS: the use of simian fibroblasts as an alternative source of target cells for chromium release assaysS Sharpe, B Beer, G Hall, et al.
Veterinary Microbiology|October 9, 1999
Treatment of feline leukemia virus (FeLV) infectionK Hartmann, A Block, G Ferk, et al.
European Journal of Pharmacology|June 7, 1985
Interaction of amoxapine with muscarinic cholinergic receptors: an in vitro assessmentJ Coupet, S K Fisher, C E Rauh, et al.
Pageof 9